Industry analyst Jim Miller will provide insight into the past, present, and future of the contract services market at the CPhI North America conference on Wednesday, April 25, 2018 in Philadelphia, PA.
Jim Miller, veteran industry analyst and founder/former president of PharmSource, a GlobalData company, will explore 20-years’ worth of changes in the contract services market during his keynote addressContract Services Yesterday, Today, and Tomorrow: A Retrospective with Jim Miller at the CPhI North America conference on Wednesday, April 25, 2018 in Philadelphia, PA.
Moderated by Rita Peters, editorial director at Pharmaceutical Technology, the presentation will also cover the impact of recent shifts in the pharma development, manufacturing, distribution, and regulatory landscape on both bio/pharma companies and contract service providers.
For more information, please visit www.cphinorthamerica.com.
Source: CPhI North America
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.